These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 35605971)
1. PSMA5 contributes to progression of lung adenocarcinoma in association with the JAK/STAT pathway. Lu F; Zhou J; Chen Q; Zhu J; Zheng X; Fang N; Qiao L Carcinogenesis; 2022 Aug; 43(7):624-634. PubMed ID: 35605971 [TBL] [Abstract][Full Text] [Related]
2. MiR-30a-3p Suppresses the Growth and Development of Lung Adenocarcinoma Cells Through Modulating GOLM1/JAK-STAT Signaling. Ding D; Zhang Y; Zhang X; Shi K; Shang W; Ying J; Wang L; Chen Z; Hong H Mol Biotechnol; 2022 Oct; 64(10):1143-1151. PubMed ID: 35438415 [TBL] [Abstract][Full Text] [Related]
3. IL4I1 enhances PD-L1 expression through JAK/STAT signaling pathway in lung adenocarcinoma. Zhu J; Li Y; Lv X Immunogenetics; 2023 Feb; 75(1):17-25. PubMed ID: 36056935 [TBL] [Abstract][Full Text] [Related]
4. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma. Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692 [TBL] [Abstract][Full Text] [Related]
5. LncRNA IGFBP4-1 promotes tumor development by activating Janus kinase-signal transducer and activator of transcription pathway in bladder urothelial carcinoma. Li C; Cao Y; Zhang L; Li J; Wu H; Ling F; Zheng J; Wang J; Li B; He J; Xie X; Li Z; Chen Y; He X; Guo M; Wei H; Ye J; Guo Y; Zhang S; Liu L; Liu G; Liu C Int J Biol Sci; 2020; 16(13):2271-2282. PubMed ID: 32760196 [TBL] [Abstract][Full Text] [Related]
6. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942 [TBL] [Abstract][Full Text] [Related]
7. Integrated analyzes identify CCT3 as a modulator to shape immunosuppressive tumor microenvironment in lung adenocarcinoma. Huang J; Hu B; Yang Y; Liu H; Fan X; Zhou J; Chen L BMC Cancer; 2023 Mar; 23(1):241. PubMed ID: 36918801 [TBL] [Abstract][Full Text] [Related]
8. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway. Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503 [TBL] [Abstract][Full Text] [Related]
9. The Silence of PSMC6 Inhibits Cell Growth and Metastasis in Lung Adenocarcinoma. Zhang JY; Shi KZ; Liao XY; Li SJ; Bao D; Qian Y; Li DJ Biomed Res Int; 2021; 2021():9922185. PubMed ID: 34239933 [TBL] [Abstract][Full Text] [Related]
10. RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK/c-Jun pathway. Zhang D; Jiang Q; Ge X; Shi Y; Ye T; Mi Y; Xie T; Li Q; Ye Q Int J Biol Sci; 2021; 17(10):2622-2632. PubMed ID: 34326698 [TBL] [Abstract][Full Text] [Related]
11. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis. Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047 [No Abstract] [Full Text] [Related]
12. Nucleophosmin promotes lung adenocarcinoma cell proliferation, migration and invasion by activating the EGFR/MAPK signaling pathway. Li M; Wu R; Zhu D; Wang L; Liu S; Wang R; Deng C; Zhang S; Chen M; Lu R; Zhu H; Mo M; Luo Z Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37165929 [TBL] [Abstract][Full Text] [Related]
13. Proteasome 26S subunit, non-ATPase 1 (PSMD1) facilitated the progression of lung adenocarcinoma by the de-ubiquitination and stability of PTEN-induced kinase 1 (PINK1). Liu L; Liu A; Dong J; Zuo Z; Liu X Exp Cell Res; 2022 Apr; 413(2):113075. PubMed ID: 35192838 [TBL] [Abstract][Full Text] [Related]
14. CCNE1 Promotes Progression and is Associated with Poor Prognosis in Lung Adenocarcinoma. Ma G; Yang L; Dong J; Zhang L Curr Pharm Biotechnol; 2022; 23(9):1168-1178. PubMed ID: 34792009 [TBL] [Abstract][Full Text] [Related]
15. Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis. Zeng B; Ge C; Li R; Zhang Z; Fu Q; Li Z; Lin Z; Liu L; Xue Y; Xu Y; He J; Guo H; Li C; Huang W; Song X; Huang Y Biomed Pharmacother; 2020 Jan; 121():109562. PubMed ID: 31707341 [TBL] [Abstract][Full Text] [Related]
16. Identification and validation of LINC01322 as a potential prognostic biomarker and oncogene promoting tumor progression in lung adenocarcinoma. Zeng L; Mi K; Peng L; Wen H; Jiao T; Lyu X; Jiao T; Chen Y; Yuan J; Zhang L; Yang S Int J Biochem Cell Biol; 2024 Apr; 169():106552. PubMed ID: 38403048 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma. Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818 [No Abstract] [Full Text] [Related]
18. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133 [TBL] [Abstract][Full Text] [Related]
19. Circular RNA CDR1-AS contributes to pemetrexed and cisplatin chemoresistance through EGFR/PI3K signaling pathway in lung adenocarcinoma. Mao Y; Xu R Biomed Pharmacother; 2020 Mar; 123():109771. PubMed ID: 31881486 [TBL] [Abstract][Full Text] [Related]
20. Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma. Wu Q; Li R; Wang QX; Zhang MY; Liu TT; Qu YQ J Transl Med; 2022 Jun; 20(1):260. PubMed ID: 35672776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]